Chun-Mei Bai (Chunmei Bai)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Venues

Therapeutic advances in medical oncology

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Peking Union Medical College Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Peking Union Medical College Hospital Jul 15 1989

China

chief/professor :: medical oncology

Publications

Zhou Zhu, Hui Tang, Jinrong Ying, Yuejuan Cheng, Xiang Wang, Yingyi Wang, Chun-Mei Bai
Efficacy and safety of gemcitabine plus S-1 vs. gemcitabine plus nab-paclitaxel in treatment-naïve advanced pancreatic ductal adenocarcinoma. Cancer biology & medicine (2023)
Kaili Yang, Jiarui Li, Yuejuan Cheng, Chun-Mei Bai
Evolving landscape of clinical trials in gastroenteropancreatic neuroendocrine neoplasms in the past two decades. Endocrine connections 12 (4) (2023)
Tian-Shu Liu, Yuxian Bai, Xiaoyan Lin, Wei Li, Jufeng Wang, Xiaochun Zhang, Hongming Pan, Chun-Mei Bai, Li Bai, Ying Cheng, Jingdong Zhang, Haijun Zhong, Yi Ba, Wenwei Hu, Rui-Hua Xu, Weijian Guo, Shukui Qin, Nong Yang, Jianwei Lu, Kohei Shitara, Ming Lei, Mingshun Li, Nicole Bao, Tian Chen, Lin Shen
First-line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis. International journal of cancer (2022)
Hui Tang, Caixia Qiao, Yingyi Wang, Chun-Mei Bai
Characteristics and Prognostic Nomogram for Primary Lung Lepidic Adenocarcinoma. Canadian respiratory journal 2022 (2022)
Ningning Li, Chun-Mei Bai, Lin Zhao, Yuping Ge, Xiaoyuan Li
Characterization of the fecal microbiota in gastrointestinal cancer patients and healthy people. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 24 (6) (2022)
Jian-Ming Xu, Yuxian Bai, Hui-Chuan Sun, Chun-Mei Bai, Ru Jia, Yi Li, Wenjie Zhang, Lei Liu, Cheng Huang, Mei Guan, Jinghong Zhou, Weiguo Su
A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer. Cancer 127 (21) (2021)
Xicheng Wang, Jianfeng Zhou, Yan Li, Yuping Ge, Yanping Zhou, Chun-Mei Bai, Lin Shen
Pharmacokinetics, Safety, and Preliminary Efficacy of Oral Trifluridine/Tipiracil in Chinese Patients with Solid Tumors: A Phase 1b, Open-Label Study. Clinical pharmacology : advances and applications 12 (2020)
Kaili Yang, Jiarui Li, Zhao Sun, Lin Zhao, Chun-Mei Bai
Retreatment with immune checkpoint inhibitors in solid tumors: a systematic review. Therapeutic advances in medical oncology 12 (2020)
Jiarui Li, Haoxuan Kan, Lin Zhao, Zhao Sun, Chun-Mei Bai
Immune checkpoint inhibitors in advanced or metastatic mucosal melanoma: a systematic review. Therapeutic advances in medical oncology 12 (2020)
Xiang Wang, Ruixing Zhang, Nan Du, Mudan Yang, Aimin Zang, Likun Liu, Junyan Yu, Jinghua Gao, Junping Zhang, Zhanzhao Fu, Yuchuan Ren, Liwen Ma, Jun Guo, Qingshan Li, Xiaomei Li, Zaiwen Fan, Xiang Song, Zheng Liu, Yan Zhang, Guozhong Li, Zhonghe Yu, Jianfeng Diao, Junmei Jia, Feng Liang, Huaqing Wang, Junzhong Sun, Yunge Gao, Ping Yang, Chun-Mei Bai, Xiubao Ren, Diansheng Zhong
An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202). Therapeutic advances in medical oncology 12 (2020)
Ying-Yi Wang, Na Zhou, Hong-Sheng Liu, Xiao-Lei Gong, Rui Zhu, Xiao-Yuan Li, Zhao Sun, Xu-Hong Zong, Ning-Ning Li, Chang-Ting Meng, Chun-Mei Bai, Tai-Sheng Li
Circulating activated lymphocyte subsets as potential blood biomarkers of cancer progression. Cancer medicine 9 (14) (2020)

Chun-Mei Bai.css-eqlu8i{font-size:small;padding-left:4px;} (Chunmei Bai)

Publication Activity (10 Years)

Top Topics

Top Venues

Chun-Mei Bai (Chunmei Bai)